The prevalence of obstructive sleep apnea (OSA) in the intensive care unit (ICU) has been reported between 6-10%. There is limited data whether there is any mortality impact of OSA in critical care setting. The purpose of this study is to compare in-hospital mortality between patients wiith versus without OSA who required invasive mechanical ventilation (IMV). METHODS: We performed a retrospective cohort study in subjects who admitted in critical care units using Medical Information Mart for Intensive Care-III (MIMIC-III) database. All patients who required IMV were included. Patients were categorized into OSA and non-OSA group. Demgraphic data, comorbidities, length of IMV, hospital length of stay (LOS), Simplified Acute Physiology Scores-II (SAPS-II), in-hospital mortality were collected. Propensity score-matched analysis for gender, ethnicity and SAPS-II was performed. RESULTS: There were 923 and 20,464 patients with OSA and without OSA, respectively. In-hospital mortality were 17.6% in total, 8.7% and 18% in OSA and non-OSA group, respectively (p<0.01). There was no significant difference of ventilator duration or hospital LOS. After propensity score matching was performed, the in-hospital mortality were 8.7% and 15.3% in OSA and non-OSA group, respectively (p<0.01). Median ventilator duration were 17.3 and 19.0 hours in OSA and non-OSA group, respectively (p¼0.35). Median hospital LOS were 10.1 and 9.7 days in OSA and non-OSA group, respectively (p¼0.53). CONCLUSIONS: Critically-ill patients who required IMV with OSA had lower in-hospital mortality than patients without OSA. CLINICAL IMPLICATIONS: This result might help decreasing hesitancy to place IMV in critically-ill OSA patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.